Zoghbi Huda Y — SEC Form 4 filings
SEC reporting owner CIK 1681643. 5 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-01-04 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 3 filings — 3,555 shares, $2,925,112 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 1,117 shares @ $900.00 ($1,005,300) in REGENERON PHARMACEUTICALS, INC., filed 2024-01-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | Director | 5 | — | 13 legs · 3,555 sh · $2,925,112 | 12 |
Form 4 filings — Zoghbi Huda Y
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 800 @ $376.69 · Sale (S): 800 @ $800 · Option exercise (M): 800 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,638 @ $376.69 · Sale (S): 49 @ $774.68 · Sale (S): 50 @ $775.50 · Sale (S): 53 @ $778.47 · Sale (S): 208 @ $779.55 · Sale (S): 331 @ $780.45 · +7 more | EDGAR |
| 2026-01-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 155 @ $0 · Grant/award (A): 1,962 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 166 @ $0 · Grant/award (A): 1,958 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,117 @ $391.92 · Sale (S): 1,117 @ $900 · Grant/award (A): 135 @ $0 · Option exercise (M): 1,117 (derivative) @ $0 · Grant/award (A): 1,607 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-03 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1681643 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →